J.Henderson Gl.Life Sciences F.H1/  IE00BRJ9D748  /

Fonds
NAV4/11/2024 Chg.-0.0300 Type of yield Investment Focus Investment company
32.3200GBP -0.09% paying dividend Equity Worldwide Janus Henderson Inv. 
 

Investment goal

The Fund seeks long - term growth of capital by investing primarily in life - science equity securities of companies located anywhere in the world and selected for their growth potential.
 

Master data

Type of yield: paying dividend
Funds Category: Equity
Region: Worldwide
Branch: Sector Health / Pharma
Benchmark: MSCI World Healthcare Index
Business year start: 1/1
Last Distribution: 4/14/2023
Depository bank: J.P. Morgan SE Dublin Branch
Fund domicile: Ireland
Distribution permission: Austria, Germany, Switzerland
Fund manager: Andy Acker, Daniel Lyons
Fund volume: 3.91 bill.  USD
Launch date: 10/20/2014
Investment focus: -

Conditions

Issue surcharge: 0.00%
Max. Administration Fee: 0.80%
Minimum investment: 2,500.00 GBP
Deposit fees: -
Redemption charge: 0.00%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: Janus Henderson Inv.
Address: 201 Bishopsgate, EC2M 3AE, London
Country: United Kingdom
Internet: www.janushenderson.com/
 

Assets

Stocks
 
99.41%
Cash
 
0.57%
Others
 
0.02%

Countries

United States of America
 
73.26%
Denmark
 
6.22%
United Kingdom
 
4.01%
Switzerland
 
3.49%
France
 
2.46%
Ireland
 
2.19%
Japan
 
1.67%
Netherlands
 
1.53%
Virgin Islands (British)
 
1.04%
China
 
0.99%
Cash
 
0.57%
Cayman Islands
 
0.29%
Canada
 
0.23%
Others
 
2.05%

Branches

Pharma/Biotechnology
 
61.36%
Healthcare services
 
17.28%
Healthcare appliances
 
17.14%
Parma, wholesale
 
1.61%
Cash
 
0.57%
Others
 
2.04%